Yong Qi

Yong Qi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAshaq Ali
Ashaq Ali
Muhammad NomanMuhammad Noman
Muhammad Noman
YGYong Guo
Yong Guo
XLXu Liu
Xu Liu
RZRong Zhang
Rong Zhang
DMDong Men
Dong Men
Since the emergence of SARS-CoV-2, numerous studies have been attempting to determine biomarkers, which could rapidly and efficiently predict COVID-19 severity, however there is lack of consensus on a specific one. This retrospective cohort study is a comprehensive analysis of the initial symptoms, comorbidities and laboratory evaluation of patients, diagnosed with COVID-19 in Huoshenshan Hospital, Wuhan, from 4th February to 12th March, 2020. Based on the data collected from 63 severely ill patients from the onset of symptoms till the full recovery or demise, we found not only age (average 70) but also blood indicators as significant risk factors associated with multiple organ failure. The blood indices of all patients showed hepatic, renal, cardiac and hematopoietic dysfunction with imbalanced coagulatory biomarkers. We noticed that the levels of LDH (85%, P < .001), HBDH (76%, P < .001) and CRP (65%, P < .001) were significantly elevated in deceased patients, indicating hepatic impairment. Similarly, increased CK (15%, P = .002), Cre (37%, P = 0.102) and CysC (74%, P = 0.384) indicated renal damage. Cardiac injury was obvious from the significantly elevated level of Myoglobin (52%, P < .01), Troponin-I (65%, P = 0.273) and BNP (50%, P = .787). SARS-CoV-2 disturbs the hemolymphatic system as WBC# (73%, P = .002) and NEUT# (78%, P < .001) were significantly elevated in deceased patients. Likewise, the level of D-dimer (80%, P < .171), PT (87%, P = .031) and TT (57%, P = .053) was elevated, indicating coagulatory imbalances. We identified myoglobin and CRP as specific risk factors related to mortality and highly correlated to organ failure in COVID-19 disease.

2 February 2026 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
YLYan Liu
Yan Liu
LLLei Liu
Lei Liu
JDJinbing Du
Jinbing Du
WNWenxu Ni
Wenxu Ni
TZTingting Zou
Tingting Zou
WLWanbing Liu
Wanbing Liu
Platelet-rich plasma (PRP) is known as an autologous biological agent that can immensely promote wound healing. Bacterial infection is a common complication of wounds which obstructs wound healing. However, the effect of PRP on bacteria is still inconclusive. This in vitro study evaluated the antibacterial activity of PRP, platelet-poor plasma (PPP) and Frozen-PRP (Fro-PRP) against Escherichia coli , Klebsiella pneumoniae , Enterobacter cloacae , Staphylococcus aureus , and Enterococcus faecalis . The antimicrobial activity was performed using modified agar diffusion method, colony-forming units counting test, and bacterial growth curve analysis. The results showed that PRP, PPP and Fro-PRP had antimicrobial effects on five bacterial strains including Escherichia coli , Klebsiella pneumoniae , Enterobacter cloacae , Staphylococcus aureus , and Enterococcus faecalis . The antimicrobial activity of PRP was significantly stronger than that of Fro-PRP and PPP. To a certain extent, frozen storage may reduce the antibacterial ability of PRP. Overall, our study demonstrates that PRP and other platelet derived products seem to be a promising alternative tool for infected wounds treatment.

9 July 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HMHui Meng
Hui Meng
LTLi Tan
Li Tan
YCYing Chen
Ying Chen
DWDongmei Wang
Dongmei Wang
YQYong Qi
Yong Qi
CZChuchao Zhu
Chuchao Zhu
Background: Cervical cancer (CESC) is a major gynecological malignancy, and abnormalities in phosphoinositide metabolism (PPM) are closely linked to tumor progression. This study aimed to screen phosphoinositide metabolism-related genes (PPM-RGs) with prognostic value for CESC and explore their molecular mechanisms and clinical significance. Methods: CESC transcriptomic datasets and PPM-RGs were retrieved from public databases. Differentially expressed genes were intersected with PPM-RGs to obtain candidate genes. Prognostic genes were screened via univariate Cox regression and proportional hazards assumption test, and a risk model was constructed using random survival forest (RSF). Independent prognostic analysis and nomogram establishment were performed, followed by pathway enrichment, immune infiltration, somatic mutation and single-cell analyses to characterize the tumor microenvironment. Immunohistochemical staining was used to verify the protein expression of key genes in CESC tissues. Results: Twenty candidate genes were initially identified, and two protective prognostic genes VAC14 and INPP5K were finally determined. The risk model showed favorable predictive performance with area under the curve (AUC) over 0.7, and high-risk patients had poorer survival. The nomogram combining risk score and M stage presented high accuracy. The high-risk group exhibited distinct pathway enrichment, altered immune infiltration and low somatic mutation rates. Monocytes were identified as potential key cells with impaired communication and differentiation in CESC. Immunohistochemistry confirmed downregulated expression of the two genes in CESC epithelial cells. Conclusion: VAC14 and INPP5K were PPM-related prognostic genes for CESC. Monocytes played critical roles in CESC progression. The risk model and nomogram aided prognosis prediction, providing new insights for CESC treatment.